INDOCO REMEDIES LTD

Overview

INDOCO REMEDIES LTD is an active pharmaceutical ingredient (API) supplier with 21 active FDA Type II Drug Master Files, covering ALLOPURINOL USP; ALOGLIPTIN BENZOATE; APIXABAN; ARIPIPRAZOLE USP; BESIFLOXACIN HYDROCHLORIDE; BETAXOLOL HYDROCHLORIDE USP.

API / Drug Master Files

INDOCO REMEDIES LTD holds 21 active (24 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• RIVAROXABAN USPActive2022-11-10
• LACOSAMIDE USP (PROCESS II)Active2022-03-17
• METOPROLOL SUCCINATE USPActive2020-09-24
• ARIPIPRAZOLE USPActive2019-07-03
• NEOSTIGMINE METHYLSULFATE USPActive2016-11-30
• CANAGLIFLOZINActive2016-10-18
• APIXABANActive2016-07-20
• ALOGLIPTIN BENZOATEActive2016-06-30
• LACOSAMIDE USPActive2015-07-10
• BESIFLOXACIN HYDROCHLORIDEActive2015-07-07
• FEBUXOSTAT HEMIHYDRATE (FORM G)Active2015-02-11
• BRINZOLAMIDE USPActive2014-04-02
• RASAGILINE MESYLATEActive2013-11-12
• BETAXOLOL HYDROCHLORIDE USPActive2011-09-22
• BROENAC SODIUMActive2011-08-18

Showing 15 of 24 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to INDOCO REMEDIES LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.